Agilent Technologies, Inc. - Diagnostics and Genomics SS Tumor Map Assay DNA Kit, 96A
The Agilent SureSelect Tumor MAP DNA Kit, 96 reactions (G9967C), is designed for use in targeted next-generation sequencing (NGS) applications. This kit enables the preparation of DNA libraries from tumor samples, facilitating the detection of somatic variants across a comprehensive panel of cancer-related genes. The kit includes reagents optimized for high sensitivity and specificity, supporting robust performance with low-input and challenging samples. It is compatible with Illumina sequencing platforms and is intended for research use only, providing reliable results for cancer genomics studies and biomarker discovery.